Common Stock (par value $0.01 per share) Capital on Demand™ Sales AgreementElicio Therapeutics, Inc. • June 3rd, 2024 • Pharmaceutical preparations • New York
Elicio Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
